tiprankstipranks
Trending News
More News >
D.N.A Biomedical Solutions Ltd (IL:DNA)
:DNA
Israel Market

Dna Group (DNA) Income Statement

Compare
0 Followers

Dna Group Income Statement

Last quarter (Q2 2024), Dna Group's total revenue was 76.50K, a decrease of 0.00% from the same quarter last year. In Q2, Dna Group's net income was 9.39M. See Dna Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
306.00K 306.00K 560.00K 0.00 0.00
Gross Profit
306.00K 306.00K 560.00K 0.00 0.00
Operating Expenses
-20.31M 3.72M 6.26M 2.37M 1.59M
Depreciation and Amortization
0.00 1.24M 5.70M 2.37M 1.59M
EBITDA
-1.51M -2.17M 0.00 0.00 0.00
Operating Income
20.61M -3.41M -24.33M 9.54M -17.54M
Other Income/Expenses
2.79M 2.23M 792.00K 8.83M -1.73M
Pretax Income
23.40M -1.18M -23.54M 18.37M -19.27M
Net Income
22.10M -1.18M -23.54M 18.37M -19.27M
Per Share Metrics
Basic EPS
0.00 -0.01 -0.20 0.21 -0.63
Diluted EPS
0.00 -0.01 -0.20 0.21 -0.63
Weighted Average Shares Outstanding
0.00 117.70M 116.57M 86.62M 30.46M
Weighted Average Shares Outstanding (Diluted)
0.00 123.16M 116.57M 88.23M 30.46M
Currency in ILS

Dna Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis